Science
A new coronavirus variant may be behind California's COVID rise
Coronavirus transmission is once again spiking in California entering the winter holiday season — and a new subvariant may be partly to blame, officials say.
This latest subvariant, JN.1, is now estimated to account for roughly 44% of COVID-19 cases nationally, according to the latest data from the U.S. Centers for Disease Control and Prevention.
That share is twice as high as any other identified subvariant, and a startling rise from the prior estimate of 21% for the two-week period that ended Dec. 9.
“We’re also seeing an increasing share of infections caused by JN.1 in travelers, wastewater and most regions around the globe,” the CDC said in a statement. “JN.1’s continued growth suggests that the variant is either more transmissible or better at evading our immune systems than other circulating variants.”
The World Health Organization this week classified JN.1 as a “variant of interest,” meaning it has potentially concerning characteristics — such as an ability to more easily infect individuals or avoid the protection afforded by vaccines and therapeutics.
Current vaccines, anti-COVID drugs and tests continue to work well against JN.1, the CDC said.
JN.1 is an offshoot of another Omicron subvariant, BA.2.86, which was unofficially nicknamed Pirola.
Pirola was already deemed worrisome because of its unusually high number of mutations, which might empower it to more easily infect those who haven’t received a recent COVID-19 vaccination. JN.1 has an additional mutation.
Experts say all those mutations mean it’s likely that people who have been relying on older vaccinations received more than a year ago, or a previous infection earlier this year, may not be protected enough to avoid a new run-in with the coronavirus this winter.
“It is possible that at least part of the local increase in transmission is driven by new COVID-19 strains gaining dominance in Los Angeles County, including JN.1,” the county Department of Public Health said in a statement.
Doctors say the rise of JN.1 is another reason why people — especially those who are older — should get the latest COVID-19 vaccination that became available in September.
Coronavirus transmission and COVID-19 hospitalizations, though undoubtedly on the rise, aren’t at the levels seen at this same time last year.
But the increase has been sharp. For the week ending Dec. 16, there were 2,924 new coronavirus-positive hospital admissions in California, up nearly 50% from a month earlier.
And it’s not just COVID-19. Clinics in Southern California report being busy with other viral illnesses, too — namely flu and respiratory syncytial virus, or RSV.
“Definitely, we’re seeing more people that are coming through the door, especially the younger and the older,” said Dr. Daisy Dodd, an infectious disease specialist with Kaiser Permanente Orange County. People with underlying medical issues, such as diabetes and asthma, she added, are “much more symptomatic.”
In L.A. County, about 18% of specimens tested at sentinel labs are coming back positive for flu, as are 12% of specimens tested for RSV and 11% tested for the coronavirus. The test positive rates of flu and the coronavirus are continuing to grow, while the rate for RSV has plateaued at a high level.
Coronavirus levels recorded in L.A. County’s wastewater have doubled over the last month. For the week ending Dec. 9, the most recent data available, viral levels in sewage were at 39% of the peak seen last winter, the most recent major spike for the region.
But the increase in infections, to this point, has not translated into a surge of people needing intensive care, Dodd said.
At UC San Francisco, there are now 27 coronavirus-positive patients who are currently hospitalized, up from around 20 a few weeks ago. Earlier in November, that census was in the 10s, said Dr. Peter Chin-Hong, an infectious disease specialist there.
“That is probably fueled by this new variant, JN.1,” Chin-Hong said. “It’s not that the variant causes people to be sicker. It’s just that if a lot of people are infected, a proportion of them will go to the hospital. And the more people that get infected, that number is higher.”
Notably, COVID-19, flu and RSV seem to be all “colliding this year,” Chin-Hong said. “Last year, RSV would have gone down by now.”
Other factors in the spread of COVID-19, which have been seen consistently this time of year since the pandemic began, are holiday travel and gatherings indoors. And in the first holiday season since the end of COVID’s emergency phase, people are perhaps not being as cautious as they once were in terms of testing or staying at home if they are sick.
Dr. Rafael Montalvo — chair of the urgent care department for the Facey Medical Group, which oversees clinics in Burbank, Mission Hills and Valencia — said some patients who are sick have been fairly nonchalant about their illness and are eager to work or remain out and about. Healthcare workers, he said, take care to try to convince patients to stay home when they’re ill.
“They’re actually pretty surprised when they [found out they’ve] come down with COVID,” Montalvo said. Unlike before, when people might have known where they picked up the coronavirus, “now, they’re not aware of any direct exposures.”
For the week ending Dec. 16, there were an average of 601 coronavirus-positive people in L.A. County’s hospitals, up about 66% from the prior month.
The burden COVID is posing on L.A. County’s health system is still relatively low, however. For the week that ended Dec. 9, L.A. County was reporting 6.5 new coronavirus-positive hospital admissions for every 100,000 residents, which is considered a low level as defined by the CDC.
Still, there may be some warning signs. There were 24 new COVID outbreaks in skilled nursing facilities for the week that ended Tuesday, which represents a medium level of concern in the county’s established rubric. And for the week that ended Sunday, 5% of emergency department encounters in L.A. County were classified as related to the coronavirus, also enough to warrant a medium level of concern.
In Santa Clara County, Northern California’s most populous, coronavirus levels in the San Jose area’s sewage are at 62% of last winter’s peak.
Hospital conditions are worse elsewhere. Fresno County, which like the wider Central Valley has been particularly hard hit throughout the pandemic, said its hospitals are reporting “severely impacted conditions … due to a historic number of admitted patients and people accessing the emergency department with non-urgent medical problems.”
Fresno County’s hospitals are operating at least 20% to 40% over capacity, and “are holding admitted patients in their emergency department for up to four days and are using conference rooms and non-patient areas to hold patients,” the local Department of Public Health said in a statement. Emergency room waiting times are now routinely exceeding 10 hours for some patients.
“We need everyone’s help to slow down the number of people using the emergency room for non-emergency medical issues,” Dan Lynch, the county’s emergency medical services director, said in a statement.
The CDC recommends that virtually everyone age 6 months and older get a fresh COVID-19 and flu vaccination this winter. RSV vaccinations are also available for babies, those age 60 and older, and those who are pregnant.
Uptake of the most recent COVID-19 vaccination has been lackluster, however. Across California as of Nov. 30, 27% of seniors age 65 and up have received the latest shot. That rate is 21% in L.A. County, 25% in Orange County, and 27% in San Diego and Ventura counties; but less than 20% in the Inland Empire.
In the San Francisco Bay Area’s most populous counties, around 40% of seniors have received the latest COVID-19 vaccination.
As of Dec. 9, just 42% of adults nationwide had received a flu shot, 18% had received an updated COVID-19 vaccine, and 17% of those age 60 and up had received an RSV vaccine, according to reports published this week by the CDC. Notably, just one in three nursing home residents were up to date with their COVID-19 vaccinations.
“Many adults who had not received the vaccines reported being open to vaccination,” one of the reports said.
The public health risk posed by JN.1 is similar to other subvariants in the sprawling Omicron family, the first version of which emerged a little more than two years ago. While these variants don’t pose the same threat as years prior, given a degree of immunity from past infections and immunizations, people who haven’t received a recent COVID-19 vaccination — particularly the new formula — are at greater risk.
“JN.1 [and other coronavirus variants] continue to cause disease and too many are falling ill, requiring hospitalizations or advanced clinical care, are dying, and developing long COVID,” Maria Van Kerkhove, WHO’s technical lead on COVID-19, wrote in a social media post. Nationally, about 1,000 coronavirus-infected people a week are dying.
Health officials have also urged people and healthcare providers to utilize anti-COVID drugs like Paxlovid when possible.
Some have been reluctant to take or prescribe the drug after reading last year of a purported “post-Paxlovid rebound,” in which COVID-19 symptoms reappear after having seemingly resolved. However, doctors have also long noted that COVID rebound can happen without taking Paxlovid. And a new study published this week by the CDC reaffirmed that COVID rebound can happen regardless of whether one takes anti-COVID drugs like Paxlovid or molnupiravir.
“Rebound should not deter providers from prescribing lifesaving antiviral treatments when indicated to prevent morbidity and mortality from COVID-19,” the report said.
CDC Director Dr. Mandy Cohen and others have urged people to take non-pharmaceutical precautions, such as wearing a mask in public settings, moving gatherings outdoors and improving ventilation, staying home when sick and avoiding people who are ill.
Other now-familiar measures include using hand sanitizer or regularly washing your hands, especially before eating, after sneezing or coughing, or while in public, the L.A. County Department of Public Health said.
“Consider talking with friends and family so they know to be cautious about gathering if they show signs of infection,” such as having a sore throat or a fever, the agency said. “Event hosts may want to consider asking their guests to test for COVID-19 before celebrations, especially if older or immunocompromised people will be present.”
California continues to require most insurers to reimburse covered people for the costs of up to eight at-home COVID tests per month, although people may need to obtain the tests through an “in-network” provider for the tests to remain free.
People who test positive for the coronavirus should isolate for at least five days following onset of symptoms or their first positive test result, whichever came first. The day a person starts having symptoms or had their first positive test is considered Day Zero, and the earliest a patient can exit isolation is by the end of Day 5.
According to the L.A. County Department of Public Health, infected people can end isolation after Day 5 if they have been fever free for 24 hours without using fever-reducing medications, and don’t have any other symptoms, or their symptoms are mild and improving.
The agency strongly recommends people get a negative rapid test result before ending isolation between Days 6 and 10. Isolation can generally end after Day 10 without needing a negative test result, unless you still have a fever.
Infected people are encouraged to wear a mask around others for a full 10 day-period following onset of symptoms or their first positive test. But the agency says that people who meet the criteria to end isolation after Day 5 can stop wearing a mask, too, if they have two consecutive negative coronavirus test results taken at least one day apart.
Science
This Cell Feeds, Grows and Reproduces. And It’s Manmade.
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of ingredients, the researchers have synthesized simple cells that feed, grow, reproduce and compete with one another for food. If these cells are not yet fully alive, they have most of the hallmarks of life.
“Life is not binary,” said Kate Adamala, a synthetic biologist who led the research. “That’s why I’m hesitant to call this ‘alive.’ There’s no clear line, as much as we would love it to be.”
Until now, scientists had never mastered the recipe for a cell that can perform so many functions, said John Glass, a synthetic biologist at the J. Craig Venter Institute in La Jolla, Calif., who was not involved in the study.
“It is dazzling that she has put these things all together,” he said.
Drew Endy, a synthetic biologist at Stanford University, said, “It’s a cell that was built, not born. It’s constructed, but it does what cells do.”
Dr. Adamala named her creation SpudCell, after its potato-like appearance. Rather than patent it, she and Dr. Endy are organizing a community of scientists to focus on making SpudCells more fully alive and adapting them to new kinds of experiments.
They and their colleagues have founded a nonprofit research organization that Dr. Endy estimates will spend hundreds of millions of dollars on the effort in the next decade. Hundreds of scientists are expected to join.
“We’re going to remember this moment,” said Roseanna Zia, a computational biologist at the University of Missouri who was not involved in the project.
Dr. Adamala and her colleagues posted a 190-page account of their work online. The research is under review for publication in a scientific journal.
Scientists hope synthetic cells can tell them things about life that natural cells cannot, including such basic questions as how many genes are necessary for a minimal form of life.
But synthetic cells also might someday be engineered to do things that natural cells can’t, like making new kinds of medicine or drawing large amounts of carbon dioxide from the atmosphere. In theory, engineered SpudCells might produce a vast range of proteins that natural cells cannot be coaxed to make, or even toxic chemicals like rocket fuel.
Now, “we can think about doing chemistry that we’re barely getting our heads around,” Dr. Glass said.
The trouble with life as we know it: mysterious, messy complexity. Our own DNA contains tens of thousands of genes, as well as millions of molecular switches turning those genes on and off. Scientists barely have a clue as to what many of those pieces of DNA are doing. Often a gene that they think they understand turns out to be performing other jobs than scientists expected.
One way to sidestep this intricacy is to simplify.
In the 1990s, a team led by the late biologist Craig Venter began studying a microbe that had fewer than 1,000 genes. The team, now led by Dr. Glass, went on to strip the microbe’s genome down to 525 essential genes.
In a 2016 paper, the team reported it didn’t know what a third of those genes were doing. Dr. Glass and his colleagues have spent the last decade trying to solve the puzzle, and they still can’t say what 56 of them do.
“There are still significant tasks that every cell has to do that we don’t know,” Dr. Glass said.
Other researchers tackled the problem from the opposite direction. Instead of working from the top down, they moved from the bottom up, seeking to combine lifeless molecules to produce a living cell.
Since the 1990s, several labs have bitten off small pieces of this problem. Some of them have perfected recipes to make hollow bubbles from oily molecules. Others have found ways to encapsulate simple genetic molecules inside those bubbles.
But scientists struggled to put these pieces together into more complex systems, let alone something that could be called a cell.
In recent years, Dr. Adamala took on one of the fundamental challenges: cell division. A natural cell divides with the help of proteins that lock together into a ring anchored to its inner wall. The ring winds itself tighter, pinching the cell in two.
Other proteins act like winches, moving DNA and other molecules into the forming cells, so that they have the ingredients necessary to keep living.
At first, Dr. Adamala tried building a simpler version of the natural system. But then she decided not to mimic real cells at all.
Biophysicists had found that if they stuck proteins on a membrane, they created pressure that made the membrane bend. Dr. Adamala and her team created bubbles that could snag proteins floating around them. When a bubble collected enough proteins, its surface began bending inward until it popped in two.
While the idea was simple, getting it to work in the lab required a year of experiments. “But once it works, it works,” Dr. Adamala said.
That success prompted the team to try to build a synthetic cell in its entirety.
The first step was to create a broth of the molecules necessary for a cell to operate. The recipe ultimately included about a hundred kinds of proteins and simple molecules required for crucial chemical reactions, such as making new proteins from genes.
The researchers also provided their synthetic cell with genes borrowed from a virus and the ubiquitous microbe Escherichia coli. They picked 36 genes for basic jobs like copying DNA.
After mixing these ingredients together into a soup, the scientists added the building blocks of membranes. They spontaneously joined together into bubbles, each engulfing some of the soup.
Many of these bubbles ended up encasing the right mix of genes, proteins and other molecules, and they started carrying out the chemical reactions seen in real cells.
As the new cells floated in flasks, Dr. Adamala and her colleagues added food. The cells slurped up small molecules through channels on their surfaces.
The scientists also put in small bubbles loaded with proteins and other molecules that were too big to fit through the channels. By bumping and fusing into one of these bubbles, the cell could feed on the treats inside.
As the cells fed, they grew. And in just a few hours, they were big enough to divide.
The scientists added a special protein to the flasks, which latched onto the surface of the cells and forced them to bend inward. Once the cells split in two, the pair of new cells kept growing.
Now the SpudCells grew, fed and reproduced. As it turned out, the cells even had a rudimentary ability to evolve.
Dr. Adamala and her colleagues created a mutant version that bound more tightly to the snack-filled bubbles floating around it. To test it, they created a 50-50 mixture of original and mutant SpudCells.
The cells competed for five generations for food. Eventually the mutants outnumbered the originals, suggesting that they were outcompeting the originals for food.
“That’s the shake-the-ground accomplishment here,” said Dr. Zia. Scientists will be able to put various synthetic cells in competition with one another and rapidly develop more sophisticated ones.
For all this evidence of life, SpudCell still has some major shortcomings. For starters, it can’t make the molecular factory that produces new proteins, called a ribosome. The cells can carry all the genes they need to build ribosomes, but for some reason the parts don’t come together.
For now, Dr. Adamala and her colleagues have to feed ready-made ribosomes to SpudCells. This solution has an expiration date, though: SpudCells can keep making proteins through five to 10 generations before they fail as their ribosomes become defective.
“I don’t want to say it dies, but it stops working,” Dr. Adamala said.
When Dr. Adamala showed SpudCell to Dr. Endy last year, he was so awestruck that he decided to help her found Biotic, the nonprofit organization intended to create a community of SpudCell researchers.
“I’m pouring my life’s work into this,” Dr. Endy said. One of the first tasks for Biotic will be to make it easier for other scientists to create SpudCells.
Dr. Adamala can create a fresh batch of them in her own lab in about a day. But that’s only because she has freezers full of purified proteins and an intimate understanding of each step of her recipe. Biotic expects to offer scientists easier recipes and provide the required ingredients.
Dr. Endy hopes that the open-source tools will encourage scientists to collaborate on building new kinds of SpudCells with more of the defining features of life, such as the ability to make their own ribosomes and to divide indefinitely.
“It’s completely doable,” said Dr. Glass.
Biotic researchers are already planning their first meeting, in September in Philadelphia. High on their list of priorities will be formalizing plans to safeguard this area of research.
For now, the synthetic cell can only survive a few generations on a special lab diet. But future versions may be more robust, raising the possibility that someone might someday use SpudCells unethically, perhaps even to make a weapon.
Dr. Endy argues that an open-source research community will be better prepared to prevent that from happening. “We can have these conversations now, as opposed to waiting for somebody else to do it, and then we’re just all reacting,” he said.
Dr. Endy likens SpudCells to a biological version of the Wright flyer, the crude plane that the Wright Brothers used to make the first sustained controlled flight in 1903, ushering in the age of airplanes.
“The Wright flyer flying for 12 seconds doesn’t get you a 737,” Dr. Endy said. “This is just the beginning.”
Science
After bold pledge, EPA shelves microplastics testing in U.S. drinking water
For the next five years, the Environmental Protection Agency has indicated it will not require public water utilities to test for microplastics or pharmaceuticals in drinking water, according to a proposed rule published in the Federal Register.
On Friday, the EPA submitted a list of chemicals it plans to test for under the Unregulated Contaminant Monitoring Rule, a mandatory testing program used to collect information about concerning chemicals in drinking water that could be harming human health. It did not include microplastics or pharmaceuticals.
The omissions come after announcements by EPA Administrator Lee Zeldin earlier this year that his agency was designating microplastics and pharmaceuticals priority contaminants for testing.
“This is a direct response to the concern of millions of Americans who have long demanded answers about what they and their families are drinking every day,” he said at an April news conference with Health and Human Secretary Robert F. Kennedy Jr. at EPA headquarters.
Zeldin’s announcement was seen at the time as a move to placate the increasingly disgruntled Make America Healthy Again contingent of Trump supporters.
Now the agency says it has no validated or standardized method to test for the plastic particles in drinking water, and wouldn’t be able to develop one before December, when testing is required to begin.
Among the 33 chemicals the EPA will require water utilities to test for are seven PFAS, or forever chemicals, and three pesticide residues.
It will be five years before the EPA proposes another list.
The EPA did not respond to a request for comment.
The agency noted in its proposed rule that it will collaborate with other federal agencies to “evaluate risks and exposures” of microplastics for future monitoring.
Environmentalists reacted with frustration and resignation. They pointed out that the European Union has developed methods to test for the tiny plastic particles, which have been found in people’s blood, brains and lung tissue. California has one in the works.
“The California water board has spent a lot of time and money on how to measure in drinking water,” said Judith Enck, a former EPA regional administrator and president of the anti-plastic environmental group Beyond Plastics. “EPA should give them a call.”
California was required by a 2018 state law to establish a protocol for local water utilities to test for the particles in drinking water. The state has not yet begun reporting its results, but protocols were established in 2021. Blair Robertson, a spokesman for the State Water Resources Control Board, said it’s not “a fully validated, end-to-end regulatory method” yet.
At the April meeting, Zeldin announced that he would place microplastics on what is known as the Contaminant Candidate List, which acts as a preliminary “watch list” of unregulated, priority contaminants in drinking water. Like the mandatory monitoring list, it is updated only every five years. The most recent list was published on April 2 — the day he made his announcement.
“Americans have been ignored as they sound the alarm about plastics in their drinking water,” Zeldin said during the announcement. “That ends today by placing microplastics on the contaminant candidate list for the first time ever. EPA will follow the science, will pursue answers and will hold ourselves to the highest standards to protect the health of Americans.”
There appears to be no clear association between these two lists, although the contaminant list is supposed to inform the monitoring list. Seventy-five chemicals and four chemical groups (microplastics, pharmaceuticals, PFAS chemicals, and disinfection byproducts) were listed on the 2026 contaminant list. Only seven of those chemicals were also on the proposed monitoring list (as well as seven PFAS chemicals).
When Zeldin announced microplastics as “‘a priority contaminant for regulation,’ and called it ‘a historic action on microplastics,’ he made it seem like the administration was going to take microplastics seriously,” said Mary Grant, water policy director for the environmental group Food & Water Watch.
“By not including them, they made it clear they don’t actually have plans to immediately address this crisis by getting the real-world monitoring data that we need right now to really start correcting ourselves,” she said.
Craig Davis, senior director of plastics chemistry at the American Chemistry Council — the nation’s largest trade group for chemical companies — said that while his organization supports microplastic research, it also agrees with the EPA’s decision not to include them in the monitoring list.
“National drinking water monitoring should be based on validated, standardized methods that can produce reliable and comparable data,” said Davis in a statement. He said “limited” national monitoring resources should be focused where data can produce “actionable public health information.”
The public has 60 days to comment once the plan is published in the Federal Register.
Science
Hospital visits for smoke inhalation spiked during Boyle Heights warehouse fire
The number of Angelenos who went to the hospital with throat pain and concerns about smoke inhalation spiked as a fire burned through the massive Lineage cold storage warehouse in Boyle Heights this month, The Times has learned.
The blaze burned for eight days beginning June 17 and involved solar panels, insulation foam and other industrial materials.
During that time, more than three times as many people went to emergency departments within 10 miles of the warehouse mentioning the fire or smoke inhalation compared with the two weeks prior, according to data from the Los Angeles County Department of Public Health obtained through a public records request.
The agency also noted a near doubling of patients mentioning throat pain within five miles of the fire June 21 — 1.9 times the baseline levels.
Usually, fewer than 50 people go to the emergency room each day for throat pain, and fewer than 20 people for smoke inhalation, the department said.
The hospitalization data was tracked through the department’s syndromic surveillance project, which monitors trends in what people report when they come to emergency departments in L.A. County, as well as diagnosis codes noted by providers. The system is not as comprehensive as full patient health records, and clinicians may not always include key words about “fire,” “smoke” or other circumstantial information in their diagnoses, the public health department said.
As such, it “cannot capture the true number of [emergency department] visits related to symptoms from the fire and likely underestimates the true burden of fire related symptoms,” the department said.
Perhaps unexpectedly, the department said it did not note a substantial increase in asthma, acute respiratory symptoms or chronic obstructive pulmonary disease-related emergency department visits during the fire.
But even these preliminary findings are concerning, experts said. The fire is believed to have started on the solar array on the roof of the 500,000 square-foot building, which housed 85 million pounds of frozen food. It then reached an ammonia line, prompting two brief shelter-in-place orders for nearby residents.
Over the next week, the fire continued to burn through dense insulation foam within the building’s walls and other unknown industrial materials, blanketing much of L.A. in acrid smoke. Residents in downtown L.A., northeast L.A., Burbank, the San Gabriel Valley and many other parts of the city and county reported seeing and smelling the fumes.
The South Coast Air Quality Management District issued multiple warnings about unhealthy levels of PM 2.5, or fine particulate matter. The city and county opened two smoke respite shelters in the immediate area so that people could breath cleaner air.
It is still unclear what exactly was in the smoke that people breathed in. Industrial fires release far more materials than the burned wood smoke that is emitted during wildfires.
“The makeup of the smoke can include toxic chemicals, fine particles and other serious risks to lung health depending on fire conditions and what is burned,” Will Barrett, assistant vice president for nationwide clean air policy at the American Lung Assn., said as the fire was burning. Children and elderly people are particularly at risk.
David Eisenman, director of the UCLA Center for Public Health and Disasters, said urban industrial fires also can represent a hazard that standard PM 2.5 warnings don’t always address. Those advisories are “blunt instruments” that don’t adequately capture emissions from burning man-made goods — or convey that the source of pollution may include burning batteries or toxic refrigerants, he said.
The fact that initial numbers don’t show a spike in asthma attacks is “somewhat reassuring,” Eisenman said. But “people may have gone to their primary care doctors, which this would not capture. This data deserves follow up.”
The air district and the U.S. Environmental Protection Agency deployed air monitors to assess particulate matter, airborne toxic metals and other harmful compounds during the early days of the blaze. The air district said it didn’t find significant levels of air toxics during the first two days of the fire, although it did record significantly elevated concentrations of particulate matter within the plume downwind.
Some of the measurements it took with mobile monitors, which are five-minute snapshots, also showed increased bromine and chlorine, which often are found when buildings burn and were at levels “below short-term health-based exposure thresholds,” the air district said. It began continuous PM 2.5. monitoring at two nearby elementary schools on the third day.
The L.A. Fire Department said it detected low-levels of toxic hydrogen fluoride on the second day of the fire, which can be a byproduct of burning lithium-ion batteries.
Lineage, the tenant-operator of the warehouse, said no concentrations of ammonia were detected in the air at any time.
“There’s no doubt this fire has had a huge impact on the local community, and we are committed to showing up in every way we can,” company officials wrote in a statement last week. They said Lineage worked closely with the Fire Department during the blaze and delivered masks, air purifiers and other supplies to the community, and will work to ensure the fastest cleanup possible.
The long-term health effects of the fire and its smoke probably won’t be known unless researchers conduct a follow-up study, said Eisenman of UCLA.
For example, there may have been delayed pulmonary effects from the hydrogen fluoride and burning insulation foam that — when combined with the elevated PM 2.5 levels in a dense urban environment — produced health effects that didn’t show up in the emergency room data.
“They will show up in increased primary care office visits and exacerbations of chronic disease over the next few weeks,” he said. “So from a public health standpoint, this fire is not over.”
-
Iowa10 seconds agoIowa’s governor and her family on weeklong tour of Iowa tourist sites – Radio Iowa
-
Kansas5 minutes agoNew mural to be unveiled Thursday afternoon in North Topeka
-
Kentucky12 minutes ago
Former Northern Kentucky school bus driver sentenced in child pornography case
-
Louisiana15 minutes agoAudit finds barriers hinder Louisiana WIC enrollment – American Press
-
Maine20 minutes agoHow to safely enjoy the water in Maine as temperatures rise
-
Maryland27 minutes agoRep. Glenn Ivey, Community Members Discuss Gun Violence Solutions
-
Michigan30 minutes agoThousands without power in mid-Michigan
-
Massachusetts35 minutes agoMass. Legislature reaches compromise on $63.4B state budget. Here’s what’s in it